GlassScriptPhysician profile
Jeffery R White
NPI 1558564641
$2,100.12
in general payments reported to CMS, 2019-2025
8 companies · $771 in 2025
The $771 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $151 · 2021: $249 · 2022: $382 · 2023: $170 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709 · Travel and Lodging: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.11 |
| Travel and Lodging | $231.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $852.54 | 2021-2025 | Mo.Ma Ultra, Protege Rx, Concertotm |
| Inari Medical, INC. | $354.53 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $327.77 | 2019-2025 | Optablate |
| Sirtex Medical INC | $174.34 | 2020-2023 | Sir-Spheres Microspheres |
| Penumbra, INC. | $148.86 | 2021 | |
| W. L. Gore & Associates, INC. | $114.87 | 2019 | |
| Medtronic Vascular, INC. | $93.43 | 2019 | |
| Ekos Corporation | $33.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffery White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.